TRAIL and interferon-α act synergistically to induce renal cell carcinoma apoptosis

Journal of Urology

Volumn 184, Issue 3, 2010, Pages 1166-1174

  Clark, Peter E ^a,b   Polosukhina, Dina A ^a   Gyabaah, Kenneth ^d   Moses, Harold L ^b   Thorburn, Andrew ^e   Zent, Roy ^a,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

carcinoma, renal cell; extracellular signal regulated MAP kinases; interferons; kidney; TNF related apoptosis inducing ligand

Indexed keywords

ALPHA INTERFERON; CALBIOCHEM; CASPASE 3; CASPASE 8; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN CLEAVAGE; WESTERN BLOTTING; DRUG EFFECT; HUMAN; KIDNEY TUMOR; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; DRUG SYNERGISM; HUMANS; INTERFERON-ALPHA; KIDNEY NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 77956637274     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.04.064     Document Type: Article

References (30)

1. R.M. Bukowski Cytokine therapy for metastatic renal cell carcinoma Semin Urol Oncol 19 2001 148
2. B.I. Rini Metastatic renal cell carcinoma: many treatment options, one patient J Clin Oncol 27 2009 3225
3. Q. Chen, B. Gong, and A.S. Mahmoud-Ahmed Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma Blood 98 2001 2183
4. M. Chawla-Sarkar, D.W. Leaman, and E.C. Borden Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines Clin Cancer Res 7 2001 1821
5. R.M. Pitti, S.A. Marsters, and S. Ruppert Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family J Biol Chem 271 1996 12687
6. S.R. Wiley, K. Schooley, and P.J. Smolak Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 673
7. A. Ashkenazi, R.C. Pai, and S. Fong Safety and antitumor activity of recombinant soluble Apo2 ligand J Clin Invest 104 1999 155
8. H. Walczak, R.E. Miller, and K. Ariail Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat Med 5 1999 157
9. S. Leong, R.B. Cohen, and D.L. Gustafson Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study J Clin Oncol 27 2009 4413
10. R. Plummer, G. Attard, and S. Pacey Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers Clin Cancer Res 13 2007 6187
11. J. Mongkolsapaya, J.M. Grimes, and N. Chen Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation Nat Struct Biol 6 1999 1048
12. S. Wang, and W.S. El-Deiry TRAIL and apoptosis induction by TNF-family death receptors Oncogene 22 2003 8628
13. H.N. LeBlanc, and A. Ashkenazi Apo2L/TRAIL and its death and decoy receptors Cell Death Differ 10 2003 66
14. J. Asakuma, M. Sumitomo, and T. Asano Selective Akt inactivation and tumor necrosis actor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel Cancer Res 63 2003 1365
15. S. Bouralexis, D.M. Findlay, and G.J. Atkins Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy Br J Cancer 89 2003 206
16. B. Gong, and A. Almasan Genomic organization and transcriptional regulation of human Apo2/TRAIL gene Biochem Biophys Res Commun 278 2000 747
17. M. Chawla-Sarkar, D.W. Leaman, and B.S. Jacobs IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis J Immunol 169 2002 847
18. T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 1984 27
19. L. Zhang, X. Zhang, and G.W. Barrisford Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model Cancer Lett 251 2007 146
20. T.S. Griffith, J.M. Fialkov, and D.L. Scott Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma Cancer Res 62 2002 3093
21. T.S. Griffith, B. Stokes, and T.A. Kucaba TRAIL gene therapy: from preclinical development to clinical application Curr Gene Ther 9 2009 9
22. R.W. Johnstone, A.J. Frew, and M.J. Smyth The TRAIL apoptotic pathway in cancer onset, progression and therapy Nat Rev Cancer 8 2008 782
23. P. Secchiero, E. Melloni, and M. Heikinheimo TRAIL regulates normal erythroid maturation through an ERK-dependent pathway Blood 103 2004 517
24. J.J. Song, and Y.J. Lee Differential cleavage of Mst1 by caspase-7/-3 is responsible for TRAIL-induced activation of the MAPK superfamily Cell Signal 20 2008 892
25. S.E. Tran, T.H. Holmstrom, and M. Ahonen MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors J Biol Chem 276 2001 16484
26. P. Li, X. Wang, and N. Li Anti-apoptotic hPEBP4 silencing promotes TRAIL-induced apoptosis of human ovarian cancer cells by activating ERK and JNK pathways Int J Mol Med 18 2006 505
27. Y.H. Kim, D.H. Lee, and J.H. Jeong Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway Biochem Pharmacol 75 2008 1946
28. D. Xiao, and S.V. Singh Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases Cancer Res 62 2002 3615
29. W.C. Lee, C.H. Choi, and S.H. Cha Role of ERK in hydrogen peroxide-induced cell death of human glioma cells Neurochem Res 30 2005 263
30. R.P. Sahu, R. Zhang, and S. Batra Benzyl isothiocyanate mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells Carcinogenesis 30 2009 1744